all_task_dict:
  OS: surv
  DFS: surv
  AGE: reg
  AJCC_METASTASIS_PATHOLOGIC_PM: cls
  AJCC_NODES_PATHOLOGIC_PN: cls
  AJCC_PATHOLOGIC_TUMOR_STAGE: cls
  AJCC_PATHOLOGIC_TUMOR_STAGE_reduced: cls
  AJCC_STAGING_EDITION: cls
  AJCC_TUMOR_PATHOLOGIC_PT: cls
  BRACHYTHERAPY_TOTAL_DOSE_POINT_A: cls
  CENT17_COPY_NUMBER: cls
  DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS: reg
  ER_POSITIVITY_SCALE_OTHER: cls
  ER_POSITIVITY_SCALE_USED: cls
  ER_STATUS_BY_IHC: cls
  ER_STATUS_IHC_PERCENT_POSITIVE: cls
  ETHNICITY: cls
  FIRST_SURGICAL_PROCEDURE_OTHER: cls
  HER2_AND_CENT17_CELLS_COUNT: reg
  HER2_AND_CENT17_SCALE_OTHER: cls
  HER2_CENT17_RATIO: reg
  HER2_COPY_NUMBER: cls
  HER2_FISH_METHOD: cls
  HER2_FISH_STATUS: cls
  HER2_IHC_PERCENT_POSITIVE: cls
  HER2_IHC_SCORE: reg
  HER2_POSITIVITY_METHOD_TEXT: cls
  HER2_POSITIVITY_SCALE_OTHER: cls
  HISTOLOGICAL_DIAGNOSIS: cls
  HISTOLOGICAL_SUBTYPE: cls
  HISTORY_NEOADJUVANT_TRTYN: cls
  HISTORY_OTHER_MALIGNANCY: cls
  ICD_10: cls
  ICD_O_3_HISTOLOGY: cls
  ICD_O_3_SITE: cls
  IHC_HER2: cls
  IHC_SCORE: reg
  INITIAL_PATHOLOGIC_DX_YEAR: reg
  LYMPH_NODES_EXAMINED: cls
  LYMPH_NODES_EXAMINED_HE_COUNT: reg
  LYMPH_NODES_EXAMINED_IHC_COUNT: reg
  LYMPH_NODE_EXAMINED_COUNT: reg
  MARGIN_STATUS_REEXCISION: cls
  MENOPAUSE_STATUS: cls
  METASTATIC_SITE_OTHER: cls
  METASTATIC_SITE_PATIENT: cls
  METASTATIC_TUMOR_INDICATOR: cls
  METHOD_OF_INITIAL_SAMPLE_PROCUREMENT: cls
  METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER: cls
  MICROMET_DETECTION_BY_IHC: cls
  NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT: cls
  NTE_CENT_17_HER2_RATIO: reg
  NTE_ER_STATUS: cls
  NTE_ER_STATUS_IHC_POSITIVE: cls
  NTE_HER2_POSITIVITY_IHC_SCORE: cls
  NTE_HER2_STATUS: cls
  NTE_PR_IHC_INTENSITY_SCORE: reg
  NTE_PR_STATUS_BY_IHC: cls
  PATH_MARGIN: cls
  PHARMACEUTICAL_TX_ADJUVANT: cls
  PRIMARY_SITE_PATIENT: cls
  PROSPECTIVE_COLLECTION: cls
  PR_POSITIVITY_DEFINE_METHOD: cls
  PR_POSITIVITY_IHC_INTENSITY_SCORE: cls
  PR_POSITIVITY_SCALE_OTHER: cls
  PR_POSITIVITY_SCALE_USED: cls
  PR_STATUS_BY_IHC: cls
  PR_STATUS_IHC_PERCENT_POSITIVE: cls
  RACE: cls
  RADIATION_TREATMENT_ADJUVANT: cls
  RETROSPECTIVE_COLLECTION: cls
  SAMPLE_COUNT: reg
  SEX: cls
  SLIDE_TYPE: cls
  STAGING_SYSTEM: cls
  STAGING_SYSTEM_OTHER: cls
  SURGERY_FOR_POSITIVE_MARGINS: cls
  SURGERY_FOR_POSITIVE_MARGINS_OTHER: cls
  SURGICAL_PROCEDURE_FIRST: cls
  TISSUE_SOURCE_SITE: cls
  TUMOR_STATUS: cls
tasks_to_run:
- AGE
- AJCC_METASTASIS_PATHOLOGIC_PM
- AJCC_NODES_PATHOLOGIC_PN
- AJCC_PATHOLOGIC_TUMOR_STAGE
- AJCC_STAGING_EDITION
- AJCC_TUMOR_PATHOLOGIC_PT
- BRACHYTHERAPY_TOTAL_DOSE_POINT_A
- CENT17_COPY_NUMBER
- DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS
- DFS_MONTHS
- DFS_STATUS
- ER_POSITIVITY_SCALE_OTHER
- ER_POSITIVITY_SCALE_USED
- ER_STATUS_BY_IHC
- ER_STATUS_IHC_PERCENT_POSITIVE
- ETHNICITY
- FIRST_SURGICAL_PROCEDURE_OTHER
- HER2_AND_CENT17_CELLS_COUNT
- HER2_AND_CENT17_SCALE_OTHER
- HER2_CENT17_RATIO
- HER2_COPY_NUMBER
- HER2_FISH_METHOD
- HER2_FISH_STATUS
- HER2_IHC_PERCENT_POSITIVE
- HER2_IHC_SCORE
- HER2_POSITIVITY_METHOD_TEXT
- HER2_POSITIVITY_SCALE_OTHER
- HISTOLOGICAL_DIAGNOSIS
- HISTOLOGICAL_SUBTYPE
- HISTORY_NEOADJUVANT_TRTYN
- HISTORY_OTHER_MALIGNANCY
- ICD_10
- ICD_O_3_HISTOLOGY
- ICD_O_3_SITE
- IHC_HER2
- IHC_SCORE
- INITIAL_PATHOLOGIC_DX_YEAR
- LYMPH_NODES_EXAMINED
- LYMPH_NODES_EXAMINED_HE_COUNT
- LYMPH_NODES_EXAMINED_IHC_COUNT
- LYMPH_NODE_EXAMINED_COUNT
- MARGIN_STATUS_REEXCISION
- MENOPAUSE_STATUS
- METASTATIC_SITE_OTHER
- METASTATIC_SITE_PATIENT
- METASTATIC_TUMOR_INDICATOR
- METHOD_OF_INITIAL_SAMPLE_PROCUREMENT
- METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER
- MICROMET_DETECTION_BY_IHC
- NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT
- NTE_CENT_17_HER2_RATIO
- NTE_ER_STATUS
- NTE_ER_STATUS_IHC_POSITIVE
- NTE_HER2_POSITIVITY_IHC_SCORE
- NTE_HER2_STATUS
- NTE_PR_IHC_INTENSITY_SCORE
- NTE_PR_STATUS_BY_IHC
- OS_MONTHS
- OS_STATUS
- PATH_MARGIN
- PHARMACEUTICAL_TX_ADJUVANT
- PRIMARY_SITE_PATIENT
- PROSPECTIVE_COLLECTION
- PR_POSITIVITY_DEFINE_METHOD
- PR_POSITIVITY_IHC_INTENSITY_SCORE
- PR_POSITIVITY_SCALE_OTHER
- PR_POSITIVITY_SCALE_USED
- PR_STATUS_BY_IHC
- PR_STATUS_IHC_PERCENT_POSITIVE
- RACE
- RADIATION_TREATMENT_ADJUVANT
- RETROSPECTIVE_COLLECTION
- SAMPLE_COUNT
- SEX
- STAGING_SYSTEM
- STAGING_SYSTEM_OTHER
- SURGERY_FOR_POSITIVE_MARGINS
- SURGERY_FOR_POSITIVE_MARGINS_OTHER
- SURGICAL_PROCEDURE_FIRST
- TISSUE_SOURCE_SITE
- TUMOR_STATUS
- SLIDE_TYPE
- AJCC_PATHOLOGIC_TUMOR_STAGE_reduced
label_dict:
  AJCC_METASTASIS_PATHOLOGIC_PM:
    M0: 0
    M1: 1
    MX: 2
    cM0 (i+): 3
  AJCC_NODES_PATHOLOGIC_PN:
    N0: 0
    N0 (i+): 1
    N0 (i-): 2
    N0 (mol+): 3
    N1: 4
    N1a: 5
    N1b: 6
    N1c: 7
    N1mi: 8
    N2: 9
    N2a: 10
    N3: 11
    N3a: 12
    N3b: 13
    N3c: 14
    NX: 15
  AJCC_PATHOLOGIC_TUMOR_STAGE:
    Stage I: 0
    Stage IA: 1
    Stage IB: 2
    Stage II: 3
    Stage IIA: 4
    Stage IIB: 5
    Stage III: 6
    Stage IIIA: 7
    Stage IIIB: 8
    Stage IIIC: 9
    Stage IV: 10
    Stage X: 11
  AJCC_PATHOLOGIC_TUMOR_STAGE_reduced:
    Stage I: 0
    Stage II: 1
    Stage III: 2
    Stage IV: 3
  AJCC_STAGING_EDITION:
    3rd: 0
    4th: 1
    5th: 2
    6th: 3
    7th: 4
  AJCC_TUMOR_PATHOLOGIC_PT:
    T1: 0
    T1a: 1
    T1b: 2
    T1c: 3
    T2: 4
    T2a: 5
    T2b: 6
    T3: 7
    T3a: 8
    T4: 9
    T4b: 10
    T4d: 11
    TX: 12
  BRACHYTHERAPY_TOTAL_DOSE_POINT_A:
    '% IHC': 0
    '>10% STAINING = POSITIVE': 1
    Allread score 5+3 = 8: 2
    Allred 0 = 0+0: 3
    Allred 7 = 5+2: 4
    Allred 8 = 5+3: 5
    Allred score 0+0 = 0: 6
    Allred score 1+1 = 2: 7
    Allred score 3 + 2 = 5: 8
    Allred score 3+2 = 5: 9
    Allred score 4+3=7: 10
    Allred score 5+2 = 7: 11
    Allred score 5+3 = 8: 12
    Allred score 5+3= 8: 13
    Allred score 5+3=8: 14
    Allred score 7 (outside facility): 15
    Allred score = 8: 16
    CAP SCORING GUIDELINE 2010: 17
    CAP scoring guideline 2010: 18
    ER Positive H-Score 95: 19
    H-SCORE 0: 20
    H-SCORE 136: 21
    H-SCORE 140: 22
    H-SCORE 180: 23
    H-SCORE 190: 24
    H-SCORE 230: 25
    H-SCORE 255: 26
    H-SCORE 260: 27
    H-SCORE 280: 28
    H-SCORE 295: 29
    H-SCORE 300: 30
    H-Score 0: 31
    H-Score 140: 32
    H-Score 150: 33
    H-Score 200: 34
    H-Score 240: 35
    H-Score 270: 36
    H-Score 280: 37
    H-Score 295: 38
    H-Score 300: 39
    H-Score-190: 40
    IHC: 41
    IMAGE ANALYSIS: 42
    Image Analysis: 43
    Immune Stain by GenPath: 44
    Immunohistochemistry: 45
    No value Given: 46
    allred score 0 + 0 = 0: 47
    allred score 5 + 3 = 8: 48
    allred score 5+3=8: 49
    dextran coated charcoal: 50
    image cytometry: 51
    manual counting: 52
  CENT17_COPY_NUMBER:
    '1.1': 0
    '1.4': 1
    '1.45': 2
    '1.5': 3
    '1.57': 4
    '1.67': 5
    '1.7': 6
    '1.73': 7
    '1.78': 8
    '1.8': 9
    '1.9': 10
    '1.93': 11
    '118': 12
    '125': 13
    '127': 14
    '160': 15
    '2': 16
    '2.08': 17
    '2.13': 18
    '2.2': 19
    '2.25': 20
    '2.3': 21
    '2.38': 22
    '2.4': 23
    '2.5': 24
    '2.6': 25
    '2.65': 26
    '2.7': 27
    '2.8': 28
    '2.9': 29
    '2.98': 30
    '3': 31
    '3.1': 32
    '3.2': 33
    '3.33': 34
    '3.7': 35
    '33': 36
    '35': 37
    '39': 38
    '4': 39
    '4.43': 40
    '40': 41
    '46': 42
    '49': 43
    '5': 44
    '50': 45
    '51': 46
    '54': 47
    '58': 48
    '63': 49
    '64': 50
    '66': 51
    '67': 52
    '68': 53
    '69': 54
    '70': 55
    '71': 56
    '74': 57
    '78': 58
    polisomy: 59
  DFS_STATUS:
    0:DiseaseFree: 0
    1:Recurred/Progressed: 1
  ER_POSITIVITY_SCALE_OTHER:
    '0': 0
    0%: 1
    10-75%: 2
    '120': 3
    '130': 4
    '170': 5
    '180': 6
    '190': 7
    '205': 8
    '210': 9
    '230': 10
    240 H: 11
    '250': 12
    '260': 13
    288 fmol/mg: 14
    49 fmol/mg protein: 15
    '7': 16
    '8': 17
    '80': 18
    '>10%': 19
    '>75%': 20
    Allred: 21
    Allred Score: 22
    Allred Score 5: 23
    Allred Score 6: 24
    Allred Score 7: 25
    Allred Score 8: 26
    Allred Score = 7: 27
    Allred score 5: 28
    Allred score 7: 29
    Allred score 7 (per outside facility): 30
    Allred score 8: 31
    Allred score = 0: 32
    Allred score = 2: 33
    Allred score = 5: 34
    Allred score = 7: 35
    Allred score = 8: 36
    H Score: 37
    H score: 38
    H-SCORE: 39
    H-Score: 40
    Intensity=Strong: 41
    Intensity=moderate: 42
    MODERATE: 43
    Moderate: 44
    Moderate using scale of Weak, Moderate, Strong: 45
    Moderate using the scale of Weak, Moderate, Strong: 46
    Oncotype Dx test: 47
    STRONG: 48
    Strong: 49
    Strong using Weak, Moderate and Strong: 50
    Two-tier: 51
    allred score = 0: 52
    allred score = 7: 53
    allred score = 8: 54
    allred scrore = 8: 55
    moderate: 56
    moderately to strongly: 57
    strong: 58
  ER_POSITIVITY_SCALE_USED:
    3 Point Scale: 0
    4 Point Scale: 1
  ER_STATUS_BY_IHC:
    Indeterminate: 0
    Negative: 1
    Positive: 2
  ER_STATUS_IHC_PERCENT_POSITIVE:
    10-19%: 0
    20-29%: 1
    30-39%: 2
    40-49%: 3
    50-59%: 4
    60-69%: 5
    70-79%: 6
    80-89%: 7
    90-99%: 8
    <10%: 9
  ETHNICITY:
    HISPANIC OR LATINO: 0
    NOT HISPANIC OR LATINO: 1
  FIRST_SURGICAL_PROCEDURE_OTHER:
    Bilateral Mastectomy: 0
    Bilateral skin sparing Mastectomy and Bilateral breast reconstruction with tissue expanders.: 1
    EXCISION WITH NEEDLE WIRE LOCALIZATION: 2
    Excision: 3
    Excisional biopsy: 4
    Excisional biospy: 5
    Fine Needle aspiration biopsy: 6
    Fine needle aspiration biopsy: 7
    L Total Mastectomy: 8
    Left segmental mastectomy with axillary lymph node dissection: 9
    Left segmental mastectomy with left axillary lymph node dissection: 10
    Left segmental mastectomy with level 1 and level 2 axillary dissection: 11
    Mastectomy: 12
    Modified Radical Masectomy: 13
    Modified radical mastectomy with left breast biopsy: 14
    Nipple Sparing Total Mastectomy: 15
    Partial Mastectomy: 16
    Partial mastectomy: 17
    Patey's Surgery: 18
    Pateys surgery: 19
    Reexc of biopsy site for gross/micro residual disease: 20
    Right Total Mastectomy and Sentinel Node Biopsy: 21
    Right segmental mastectomy: 22
    Right segmental mastectomy with sentinel lymph node and axillary lymph node biopsy: 23
    Right total mastectomy with lymph node left axillary lymph node excision: 24
    SKIN SPARING RADICAL MASTECTOMY: 25
    Segmental Mastectomy: 26
    Segmental mastectomy: 27
    Segmental mastectomy with left axillary lymph node dissection: 28
    Segmental mastectomy with sentinel axillary lymph node biopsy: 29
    Segmental mastectomy with sentinel lymph node biopsy: 30
    Segmental mastectomy with sentinel node biopsy: 31
    Surgical Resection: 32
    Surgical resection: 33
    TOTAL MASTECTOMY: 34
    Total Mastectomy: 35
    Total mastectomy: 36
    Total mastectomy with left sentinel lymph node biospy: 37
    Total mastectomy with retromammary lymph node excision: 38
    Total mastectomy with sentinel lymoh node biopsy: 39
    Total mastectomy with sentinel lymph node biopsy: 40
    Wide Excision: 41
    Wide Local Excision: 42
    Wide local excision: 43
    Wide local excision and simple mastectomy: 44
    Wide re-excisional biopsy: 45
    bilateral total mastectomies with right sentinel node biopsy: 46
    biopsy: 47
    breast conserving therapy: 48
    excisional biopsy: 49
    left segmental mastectomy with axillary sentinel lymph node biopsy: 50
    left segmental mastectomy with sentinel node dissection: 51
    localized segmental mastectomy with axillary node dissection: 52
    needle directed right breast biopsy with left segmental mastectomy with axillary lymph node dissection: 53
    needle localized segmental mastectomy: 54
    partial left mastectomy: 55
    partial mastectomy: 56
    right segmental mastectomy: 57
    right segmental mastectomy witrh axillary node dissection: 58
    right total mastectomy with sentinel lymph node dissection right reconstruction with TRAMP: 59
    segmental mastectomy: 60
    segmental mastectomy with axillary lymph node dissection: 61
    segmental mastectomy with excision of mass on chest wall and axillary node dissection: 62
    segmental mastectomy with right sentinel lymph node biopsy: 63
    segmental mastectomy with sentinel lymph node biopsy: 64
    segmental mastectomy with sentinel lymph node biopsy and wire localization: 65
    segmental mastectomy with sentinel lymph node dissection: 66
    segmental mastectomy with sentinel lymph node excision and biopsy: 67
    total mastectomy: 68
    total mastectomy and sentinel node biopsy: 69
    total mastectomy with rigth axillary lymph node and sentinel lymph node dissection: 70
    total mastectomy with sentinel lymph node biopsy with tissue reconstruction: 71
    wide local excision: 72
  HER2_AND_CENT17_SCALE_OTHER:
    '1': 0
    '>2.2 Positive': 1
    HER2 amplification - negative: 2
    Vysis AutoVysion System: 3
  HER2_COPY_NUMBER:
    '1': 0
    '1.1': 1
    '1.57': 2
    '1.62': 3
    '1.66': 4
    '1.67': 5
    '1.73': 6
    '1.8': 7
    '1.85': 8
    '1.9': 9
    '105': 10
    '114': 11
    '118': 12
    '12.45': 13
    '125': 14
    '131': 15
    '132': 16
    '145': 17
    '149': 18
    '15': 19
    '172': 20
    '185': 21
    '2': 22
    '2.2': 23
    '2.23': 24
    '2.3': 25
    '2.4': 26
    '2.5': 27
    '2.58': 28
    '2.6': 29
    '2.65': 30
    '2.8': 31
    '2.81': 32
    '2.83': 33
    '21': 34
    '269': 35
    '3': 36
    '3.2': 37
    '3.3': 38
    '3.43': 39
    '3.5': 40
    '3.53': 41
    '3.8': 42
    '366': 43
    '4.5': 44
    '4.6': 45
    '4.7': 46
    '42': 47
    '441': 48
    '47': 49
    '5': 50
    '5.65': 51
    '5.8': 52
    '52': 53
    '59': 54
    '6.4': 55
    '60': 56
    '61': 57
    '66': 58
    '68': 59
    '71': 60
    '73': 61
    '74': 62
    '79': 63
    '816': 64
    <4.0: 65
    '>6': 66
    '>6.0': 67
    not amplified: 68
  HER2_FISH_METHOD:
    '> = 2.0': 0
    '>2.2 Positive': 1
    '>= 2.0 Positive': 2
    '>=2.0 Positive': 3
    '>=2.2 Positive': 4
    CAP SCORING GUIDELINE 2007: 5
    CAP SCORING GUIDELINE 2010: 6
    CAP scoring guideline 2010: 7
    Enumerate 60 tumor cells; Ratio of HER2/Centromere 17 >=2.1 is amplified: 8
    Enumerate 60 tumor cells; ratio HER2/Centromer 17 >= 2.1 is amplified: 9
    Enumerate 60 tumor cells; ratio HER2/Centromere 17 >= 2.1 is amplified: 10
    Enumerate 60 tumor cells; ratio of HER2/Centromere 17 >= 2.1 is amplified: 11
    Enumerate 60 tumor cells; ratio of HER2/Centromere >=2.1 is amplified: 12
    Path Vysion HER-2 DNA probe kit: 13
    Path Vysion HER2 DNA Probe Kit: 14
    PathVision HER2 DNA Probe Kit: 15
    PathVysion: 16
    PathVysion HER-2 DNA Probe Kit: 17
    PathVysion HER-2 DNA Probe kit: 18
    PathVysion HER-2 DNA probe kit.: 19
    PathVysion Her-2 DNA: 20
    Pathvysion HER-2 DNA Probe Kit: 21
    Pathvysion HER2 DNA Probe Kit: 22
    Positive >2.2: 23
    RATIO > 2.2: 24
    RATIO > = 2.0: 25
    RATIO >EQUAL 2.0: 26
    Ratio >=2.0: 27
    Ratio >=2.2: 28
    ratio > 2.2 is positive: 29
  HER2_FISH_STATUS:
    Equivocal: 0
    Indeterminate: 1
    Negative: 2
    Positive: 3
  HER2_IHC_PERCENT_POSITIVE:
    10-19%: 0
    20-29%: 1
    30-39%: 2
    40-49%: 3
    50-59%: 4
    60-69%: 5
    70-79%: 6
    80-89%: 7
    90-99%: 8
    <10%: 9
  HER2_POSITIVITY_METHOD_TEXT:
    + or -: 0
    3+ POSITIVE: 1
    3+ Positive: 2
    CAP SCORING GUIDELINE 2010: 3
    CAP scoring guideline 2010: 4
    CAP scoring guidelines 2010: 5
    CISH: 6
    DAKO Hercep Test TM: 7
    DAKOHercepTest TM: 8
    Hecep Test TM DAKO: 9
    Hercep Test  TM Dako: 10
    Hercep Test TM DAKO: 11
    HercepTest TM Dako: 12
    HerceptTest TM Dako: 13
    No membrane staining or incomplete membrane staining in <10% of tumor cells is negative: 14
    Venten: 15
    dextran coated charcoal: 16
  HER2_POSITIVITY_SCALE_OTHER:
    '0': 0
    10-75%: 1
    ACIS: 2
    CISH: 3
    Dako: 4
    FISH: 5
    Hercep Test  TM Dako: 6
  HISTOLOGICAL_DIAGNOSIS:
    Infiltrating Carcinoma NOS: 0
    Infiltrating Ductal Carcinoma: 1
    Infiltrating Lobular Carcinoma: 2
    Medullary Carcinoma: 3
    Metaplastic Carcinoma: 4
    Mixed Histology (please specify): 5
    Mucinous Carcinoma: 6
    Other, specify: 7
  HISTOLOGICAL_SUBTYPE:
    Ductal/Lobular: 0
    Infiltrating Tubulo-Lobular Carcinoma: 1
    Infiltrating ductal & lobular: 2
    Infiltrating ductal and lobular carcinoma: 3
    Invasive ductal and lobular carcinoma: 4
    Invasive mixed ductal and lobular carcinoma: 5
    Lobular carcinoma with ductal features: 6
    Lobular/Ductal: 7
    Mixed infiltrating lobular and grade 1 ductal carcinoma: 8
    Mixed invasive ductal and invasive lobular: 9
    ductal and lobular features: 10
    ductal/lobular: 11
    invasive ductal and lobular carcinoma: 12
    lobular/ductal: 13
    with ductal and lobular phenotypes: 14
  HISTORY_NEOADJUVANT_TRTYN:
    'No': 0
    'Yes': 1
  HISTORY_OTHER_MALIGNANCY:
    'No': 0
    'Yes': 1
  ICD_10:
    C50.2: 0
    C50.3: 1
    C50.4: 2
    C50.5: 3
    C50.8: 4
    C50.9: 5
    C50.919: 6
  ICD_O_3_HISTOLOGY:
    8010/3: 0
    8013/3: 1
    8022/3: 2
    8050/3: 3
    8090/3: 4
    8200/3: 5
    8201/3: 6
    8211/3: 7
    8401/3: 8
    8480/3: 9
    8500/3: 10
    8502/3: 11
    8503/3: 12
    8507/3: 13
    8510/3: 14
    8520/3: 15
    8522/3: 16
    8523/3: 17
    8524/3: 18
    8541/3: 19
    8575/3: 20
    9020/3: 21
  ICD_O_3_SITE:
    C50.2: 0
    C50.3: 1
    C50.4: 2
    C50.5: 3
    C50.8: 4
    C50.9: 5
  IHC_HER2:
    Equivocal: 0
    Indeterminate: 1
    Negative: 2
    Positive: 3
  LYMPH_NODES_EXAMINED:
    'NO': 0
    'YES': 1
  MARGIN_STATUS_REEXCISION:
    Close: 0
    Negative: 1
    Positive: 2
  MENOPAUSE_STATUS:
    Indeterminate (neither Pre or Postmenopausal): 0
    Peri (6-12 months since last menstrual period): 1
    Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy): 2
    Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement): 3
  METASTATIC_SITE_OTHER:
    Abdomen: 0
    Ovary: 1
    Skin: 2
    axilaary node negative but intrammary node positive: 3
    left adrenal gland: 4
    skin: 5
  METASTATIC_SITE_PATIENT:
    Bone: 0
    Bone|Liver: 1
    Liver: 2
    Lung: 3
    Lung|Bone: 4
    Lung|Bone|Liver: 5
    Lung|Bone|Liver|Other, specify: 6
    Lung|Other, specify: 7
    Other, specify: 8
  METASTATIC_TUMOR_INDICATOR:
    'NO': 0
    'YES': 1
  METHOD_OF_INITIAL_SAMPLE_PROCUREMENT:
    Core needle biopsy: 0
    Cytology (e.g. Peritoneal or pleural fluid): 1
    Excisional Biopsy: 2
    Fine needle aspiration biopsy: 3
    Incisional Biopsy: 4
    'Other method, specify:': 5
    Tumor resection: 6
  METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER:
    Biopsy not specified: 0
    Biopsy, NOS: 1
    Lumpectomy: 2
    Modified Radical Masectomy: 3
    Patey's Suregery: 4
    Patey's Surgery: 5
    SKIN BIOPSY: 6
    Skin biopsy: 7
    Ultrasound-guided mammotome biopsy: 8
    Wide local incision: 9
    biopsy, NOS: 10
    intraoperative examination: 11
    stereotactic biopsy: 12
  MICROMET_DETECTION_BY_IHC:
    'NO': 0
    'YES': 1
  NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT:
    'NO': 0
    'YES': 1
  NTE_ER_STATUS:
    Negative: 0
    Positive: 1
  NTE_ER_STATUS_IHC_POSITIVE:
    70-79%: 0
    90-99%: 1
    <10%: 2
  NTE_HER2_POSITIVITY_IHC_SCORE:
    1+: 0
    2+: 1
  NTE_HER2_STATUS:
    Equivocal: 0
    Negative: 1
  NTE_PR_STATUS_BY_IHC:
    Negative: 0
    Positive: 1
  OS_STATUS:
    0:LIVING: 0
    1:DECEASED: 1
  PATH_MARGIN:
    Close: 0
    Negative: 1
    Positive: 2
  PHARMACEUTICAL_TX_ADJUVANT:
    'NO': 0
    'YES': 1
  PRIMARY_SITE_PATIENT:
    Left: 0
    Left Lower Inner Quadrant: 1
    Left Lower Inner Quadrant|Left: 2
    Left Lower Inner Quadrant|Left Lower Outer Quadrant: 3
    Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left: 4
    Left Lower Outer Quadrant: 5
    Left Lower Outer Quadrant|Left: 6
    Left Upper Inner Quadrant: 7
    Left Upper Inner Quadrant|Left: 8
    Left Upper Inner Quadrant|Left Lower Inner Quadrant: 9
    Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left: 10
    Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left: 11
    Left Upper Inner Quadrant|Left Upper Outer Quadrant: 12
    Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left: 13
    Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left: 14
    Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant: 15
    Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left: 16
    Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left: 17
    Left Upper Outer Quadrant: 18
    Left Upper Outer Quadrant|Left: 19
    Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant: 20
    Left Upper Outer Quadrant|Left Lower Outer Quadrant: 21
    Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left: 22
    Left|Left Lower Inner Quadrant: 23
    Left|Left Upper Inner Quadrant: 24
    Left|Left Upper Inner Quadrant|Left Lower Inner Quadrant: 25
    Left|Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant: 26
    Left|Left Upper Outer Quadrant: 27
    Right: 28
    Right Lower Inner Quadrant: 29
    Right Lower Inner Quadrant|Right: 30
    Right Lower Inner Quadrant|Right Lower Outer Quadrant: 31
    Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right: 32
    Right Lower Outer Quadrant: 33
    Right Lower Outer Quadrant|Right: 34
    Right Upper Inner Quadrant: 35
    Right Upper Inner Quadrant|Right: 36
    Right Upper Inner Quadrant|Right Lower Inner Quadrant: 37
    Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right: 38
    Right Upper Inner Quadrant|Right Upper Outer Quadrant: 39
    Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right: 40
    Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right: 41
    Right Upper Outer Quadrant: 42
    Right Upper Outer Quadrant|Right: 43
    Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant: 44
    Right Upper Outer Quadrant|Right Lower Outer Quadrant: 45
    Right Upper Outer Quadrant|Right Lower Outer Quadrant|Right: 46
    Right|Right Lower Inner Quadrant: 47
    Right|Right Lower Outer Quadrant: 48
    Right|Right Upper Inner Quadrant: 49
    Right|Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant: 50
    Right|Right Upper Outer Quadrant: 51
  PROSPECTIVE_COLLECTION:
    'NO': 0
    'YES': 1
  PR_POSITIVITY_DEFINE_METHOD:
    '%IHC': 0
    Allred 0 = 0+0: 1
    Allred 5 = 2+3: 2
    Allred 8 = 5+3: 3
    Allred score 0+0 = 0: 4
    Allred score 0+0=0: 5
    Allred score 2+2 = 4: 6
    Allred score 2+3 = 5: 7
    Allred score 3 + 2 = 5: 8
    Allred score 3+2=5: 9
    Allred score 3+3=6: 10
    Allred score 4+3 = 7: 11
    Allred score 5+2 = 7: 12
    Allred score 5+3 = 8: 13
    Allred score 5+3= 8: 14
    Allred score 5+3=8: 15
    Allred score 7 per outside facility report: 16
    Allred score = 8: 17
    CAP SCORING GUIDELINE 2010: 18
    CAP scoring guideline 2010: 19
    H-SCORE 0: 20
    H-SCORE 1: 21
    H-SCORE 120: 22
    H-SCORE 140: 23
    H-SCORE 15: 24
    H-SCORE 150: 25
    H-SCORE 162: 26
    H-SCORE 200: 27
    H-SCORE 210: 28
    H-SCORE 245: 29
    H-SCORE 250: 30
    H-SCORE 280: 31
    H-SCORE 290: 32
    H-SCORE 7: 33
    H-Score 0: 34
    H-Score 140: 35
    H-Score 15: 36
    H-Score 160: 37
    H-Score 190: 38
    H-Score 260: 39
    H-Score 290: 40
    H-Score 70: 41
    H-Score-230: 42
    IHC: 43
    IMAGE ANALYSIS: 44
    Image Analysis: 45
    Immune stain by GenPath: 46
    Immunohistochemistry: 47
    PR Negative H-Score 0: 48
    allred score 2+2 = 4: 49
    allred score 3 + 3 = 6: 50
    allred score 4 + 3 = 7: 51
    allred score 4+2=6: 52
    allred score 5 + 3 = 8: 53
    allred score 5 +3 = 8: 54
    allred score 5+3+8: 55
    dextran coated charcoal: 56
    image cytometry: 57
    manual counting: 58
  PR_POSITIVITY_IHC_INTENSITY_SCORE:
    '0': 0
    1+: 1
    2+: 2
    3+: 3
    4+: 4
  PR_POSITIVITY_SCALE_OTHER:
    '0': 0
    0%: 1
    '10': 2
    10-75%: 3
    '108': 4
    '110': 5
    '120': 6
    '140': 7
    '160': 8
    '170': 9
    '210': 10
    '230': 11
    240 H: 12
    '60': 13
    '7': 14
    70 fmol/mg: 15
    '8': 16
    <10%: 17
    '>10%': 18
    '>10% STAINING = POSITIVE': 19
    '>75%': 20
    Allread Score 8: 21
    Allred: 22
    Allred Score: 23
    Allred Score 3: 24
    Allred Score 4: 25
    Allred Score 5: 26
    Allred Score 6: 27
    Allred Score 7: 28
    Allred Score 8: 29
    Allred score 0: 30
    Allred score 5: 31
    Allred score 6: 32
    Allred score 7 per outside facility report: 33
    Allred score 8: 34
    Allred score = 0: 35
    Allred score = 2: 36
    Allred score = 4: 37
    Allred score = 5: 38
    Allred score = 7: 39
    Allred score = 8: 40
    H score: 41
    H-SCORE: 42
    H-Score: 43
    Intensity=Strong: 44
    Intensity=weak: 45
    MODERATE: 46
    Moderate: 47
    Oncotype Dx test: 48
    Strong: 49
    Strong using Weak, Moderate and Strong: 50
    Strong, using scale of Weak, Moderate and Strong: 51
    Two-tier: 52
    allred score =  8: 53
    allred score = 4: 54
    allred score = 6: 55
    allred score = 7: 56
    allred score = 8: 57
    moderate: 58
    moderately to strongly: 59
    strong: 60
  PR_POSITIVITY_SCALE_USED:
    3 Point Scale: 0
    4 Point Scale: 1
  PR_STATUS_BY_IHC:
    Indeterminate: 0
    Negative: 1
    Positive: 2
  PR_STATUS_IHC_PERCENT_POSITIVE:
    10-19%: 0
    20-29%: 1
    30-39%: 2
    40-49%: 3
    50-59%: 4
    60-69%: 5
    70-79%: 6
    80-89%: 7
    90-99%: 8
    <10%: 9
  RACE:
    AMERICAN INDIAN OR ALASKA NATIVE: 0
    ASIAN: 1
    BLACK OR AFRICAN AMERICAN: 2
    WHITE: 3
  RADIATION_TREATMENT_ADJUVANT:
    'NO': 0
    'YES': 1
  RETROSPECTIVE_COLLECTION:
    'NO': 0
    'YES': 1
  SEX:
    Female: 0
    Male: 1
  SLIDE_TYPE:
    DX1: 0
    DX2: 1
    DX3: 2
    DX4: 3
  STAGING_SYSTEM:
    Axillary lymph node dissection alone: 0
    No axillary staging: 1
    Other (specify): 2
    Sentinel lymph node biopsy plus axillary dissection: 3
    Sentinel node biopsy alone: 4
  STAGING_SYSTEM_OTHER:
    FNA plus axillary lymph node dissection: 0
    Level 1 clearance: 1
    Pateys surgery: 2
    SLN AND NON-SLN BX: 3
    SLN and non-SLN biopsy: 4
    SN+1 non sentinel node: 5
    Sentinel Lymph node biopsy and one non-sentinel lymph node biopsy: 6
    Sentinel lymph node and axillary lymph node biopsy: 7
    Sentinel lymph node and non-sentinel lymph node biopsy: 8
    Sentinel lymph node biopsy and non-sentinel lymph node biopsy: 9
    Sentinel lymph node biopsy plus non-sentinel lymph node biopsy: 10
    Sentinel lymph node biopsy x 2 and 1 non-sentinel lymph node biopsy: 11
    Sentinel lymph node dissection: 12
    Sentinel lymph node plus Level I and Level II lymph nodes: 13
    axillary ultrasound: 14
    mastectomy with TLND: 15
    sentinel + 2 non-sentinel LN: 16
    sentinel + non sentinel: 17
    sentinel LN and one non sentinel LN: 18
  SURGERY_FOR_POSITIVE_MARGINS:
    Lumpectomy: 0
    Mastectomy NOS: 1
    Modified radical mastectomy: 2
    Other: 3
  SURGERY_FOR_POSITIVE_MARGINS_OTHER:
    Left breast reexcision: 0
    Margin resection: 1
    Mastectomy: 2
    Re-Excision of Superior Margin: 3
    Re-excision of original lumpectomy site: 4
    Re-excision of the inferior margin: 5
    Reexcision: 6
    Reexcision of segmental mastectomy: 7
    Right Breast Reexcision: 8
    Right Breast reexcision: 9
    Skin excision: 10
    inner-upper margin re-excision: 11
    surgical resection: 12
  SURGICAL_PROCEDURE_FIRST:
    Lumpectomy: 0
    Modified Radical Mastectomy: 1
    Other: 2
    Simple Mastectomy: 3
  TISSUE_SOURCE_SITE:
    3C: 0
    4H: 1
    5L: 2
    5T: 3
    A1: 4
    A2: 5
    A7: 6
    A8: 7
    AC: 8
    AN: 9
    AO: 10
    AQ: 11
    AR: 12
    B6: 13
    BH: 14
    C8: 15
    D8: 16
    E2: 17
    E9: 18
    EW: 19
    GI: 20
    GM: 21
    HN: 22
    JL: 23
    LD: 24
    LL: 25
    LQ: 26
    MS: 27
    OK: 28
    OL: 29
    PE: 30
    PL: 31
    S3: 32
    UL: 33
    UU: 34
    W8: 35
    WT: 36
    XX: 37
    Z7: 38
  TUMOR_STATUS:
    TUMOR FREE: 0
    WITH TUMOR: 1
